Gelteq【GELS】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.37

買値

2.42

売値

2.50

出来高

344,715

2.23 日の範囲 3.30

1.42 52 週間の範囲 5.50

前日終値

3.29

始値

3.05

時刻

2.42

最終取引時間

平均取引量 (3 か月)

583,931

財務取引量

US$ 1,007,933

VWAP

2.924

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label...

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

Gelteq Announces 400,000 Units Enter into Production in November 2024

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-2.13	-47.3333333333	4.5	5.14	2.23	402810	3.79432035	CS
4	0.75	46.2962962963	1.62	5.5	1.42	1002157	3.82971606	CS
12	-1.63	-40.75	4	5.5	1.42	583931	3.76092875	CS
26	-1.63	-40.75	4	5.5	1.42	583931	3.76092875	CS
52	-1.63	-40.75	4	5.5	1.42	583931	3.76092875	CS
156	-1.63	-40.75	4	5.5	1.42	583931	3.76092875	CS
260	-1.63	-40.75	4	5.5	1.42	583931	3.76092875	CS

GELS - Frequently Asked Questions (FAQ)

What is the current Gelteq share price?

The current share price of Gelteq is US$ 2.37

What is the 1 year trading range for Gelteq share price?

Gelteq has traded in the range of US$ 1.42 to US$ 5.50 during the past year

銘柄コード	株価	出来高
LITMSnow Lake Resources Ltd	US$ 0.7943 (334.04%)	1.19B
NUKKNukkleus Inc	US$ 50.68 (326.60%)	53.58M
PLRZPolyrizon Ltd	US$ 3.256 (210.10%)	136.74M
QMCOQuantum Corporation	US$ 60.085 (153.31%)	22.59M
VRARGlimpse Group Inc	US$ 3.1885 (100.53%)	54.75M
XCHXCHG Ltd	US$ 2.16 (-90.74%)	11.2M
FTELFitell Corporation	US$ 5.50 (-85.67%)	1.69M
XHGXChange TED Inc	US$ 0.754 (-52.28%)	549.39k
MHUAMeihua International Medical Technologies Company Ltd	US$ 0.2755 (-43.82%)	8.86M
RNAZTransCode Therapeutics Inc	US$ 3.915 (-38.00%)	860.08k
LITMSnow Lake Resources Ltd	US$ 0.7943 (334.04%)	1.2B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.3671 (9.94%)	317.96M
CGTXCognition Therapeutics Inc	US$ 0.58295 (28.15%)	287.37M
RGTIRigetti Computing Inc	US$ 10.684 (-4.01%)	280.37M
NVDANVIDIA Corporation	US$ 128.91 (-1.14%)	277.36M

銘柄コード

株価

出来高

LITMSnow Lake Resources Ltd

US$ 0.7943

(334.04%)

1.2B

TNXPTonix Pharmaceuticals Holding Corporation

US$ 0.3671

(9.94%)

317.96M

CGTXCognition Therapeutics Inc

US$ 0.58295

(28.15%)

287.37M

RGTIRigetti Computing Inc

US$ 10.684

(-4.01%)

280.37M

NVDANVIDIA Corporation

US$ 128.91

(-1.14%)

277.36M

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Gelteq Ltd (GELS)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

GELS 最新ニュース

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

Gelteq Announces 400,000 Units Enter into Production in November 2024

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

Form NT 20-F - Notification of inability to timely file Form 20-F

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Gelteq Limited Closes US$5.2 Million Initial Public Offering

Gelteq Limited Prices US$5.2 Million Initial Public Offering

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

Gelteq Announces 400,000 Units Enter into Production in November 2024

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

Form NT 20-F - Notification of inability to timely file Form 20-F

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

GELS - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Gelteq Ltd (GELS) 銘柄情報

Gelteq Ltd (GELS)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

GELS 最新ニュース

GELS - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手